Evidence map›Paper›PMID 40303270›Full record

Observational studyPediatric diabetes2023

Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results.

Kellee M Miller, Colleen Bauza, Lauren G Kanapka, Mark A Clements, Daniel J DeSalvo, Korey Hood, Laurel H Messer, Jennifer Sherr, Katherine Bergamo, Amy Criego and 13 more

Registry-linked trialAbstract readComparative StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Pediatric diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03263494 (CGM Intervention in Teens and Young Adults With T1D), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03263494 phase3completednot on this map

CGM Intervention in Teens and Young Adults With T1D (CITY): A Randomized Clinical Trial to Assess the Efficacy and Safety of Continuous Glucose Monitoring in Young Adults 14-<25 With Type 1 Diabetes

TypeinterventionalSponsorJaeb Center for Health ResearchRan2018 to 2019Enrolled153ConditionsType 1 Diabetes MellitusArmsContinuous Glucose Monitor (CGM)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kellee M MillerT1D Exchange, St. Petersburg, FL, USA.ORCID 0000-0002-5684-8284
Colleen BauzaJaeb Center for Health Research, Tampa, FL, USA.ORCID 0000-0002-7569-2051
Lauren G KanapkaJaeb Center for Health Research, Tampa, FL, USA.ORCID 0000-0003-4440-5168
Mark A ClementsChildren's Mercy Hospital, Kansas City, MO, USA.ORCID 0000-0002-2368-0331
Daniel J DeSalvoBaylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-0440-3339
Korey HoodStanford University, Stanford, CA, USA.ORCID 0000-0001-5730-7749
Laurel H MesserBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-7493-0989
Jennifer SherrYale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-9301-3043
Katherine BergamoUniversity of North Carolina Diabetes Care Center, Chapel Hill, NC, USA.ORCID 0009-0004-2769-1398
Amy CriegoHealth Partners Institute, International Diabetes Center, St. Louis Park, MN, USA.ORCID 0009-0009-0256-2772
Emily FreinerJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.ORCID 0009-0009-1674-9618
Sarah K LyonsBaylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-3686-0112
Roshanak MonzaviChildren's Hospital Los Angeles, Los Angeles, CA, USA.ORCID 0000-0002-0523-8726
Wayne MooreChildren's Mercy Hospital, Kansas City, MO, USA.ORCID 0000-0003-0247-0826
Priya PrahaladStanford University, Stanford, CA, USA.ORCID 0000-0002-3894-4344
Jill H SimmonsVanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-4189-6718
Mark SulikRocky Mountain Diabetes & Osteoporosis Center, Idaho Falls, ID, USA.ORCID 0009-0003-1132-4545
R Paul WadwaBarbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-4139-2122
Ruth S WeinstockSUNY Upstate Medical University, Syracuse, NY, USA.ORCID 0000-0001-5859-5666
Steven M WilliChildren's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID 0000-0002-4910-2425
Kristen WilliamsNaomi Berrie Diabetes Center, Columbia University, New York City, NY, USA.ORCID 0000-0002-8464-4537
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9675-3001
CITY Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To further evaluate glycemic outcomes during the observational extension phase of the Continuous Glucose Monitoring (CGM) Intervention for Teens and Young Adults randomized clinical trial (RCT). Results: In the CGM-CGM cohort, mean hemoglobin A1c (HbA1c) decreased from 8.9% ± 0.9% (74 ± 9.8 mmol/mol) at randomization to 8.3% ± 1.3% (67 ± 14.2 mmol/mol) at 52 weeks ( Conclusions: This further evaluation of CGM supports the findings of the preceding RCT that use of CGM improves glycemic control and reduces hypoglycemia in adolescents and young adults with type 1 diabetes. This trial is registered with NCT03263494.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycemic ControlAdolescentAdultContinuous Glucose MonitoringFemaleFollow-Up StudiesGlycated HemoglobinHumansHypoglycemic AgentsMaleRandomized Controlled Trials as TopicYoung AdultBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic Agents

Identifiers

PMID40303270
PMCPMC12016685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.